Former ODE V Director Weintraub
This article was originally published in The Tan Sheet
Executive Summary
Michael Weintraub, MD, named to the Tufts University Center for the Study of Drug Development advisory board. Weintraub left FDA's Office of Drug Evaluation V on July 3, succeeded by former oncology division director Robert DeLap, MD/PhD ("The Tan Sheet" June 8, p. 1). The Tufts center is a non-profit research group that focuses on scientific, economic, legal and public policy issues regarding pharmaceutical and biopharmaceutical R&D and regulation worldwide...